GleamWall
中文EN

XAGE Longevity Health Holdings, Inc.

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · OTC · SEC CIK 1842939 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY60.3%
TTM net income YoY5.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin59.0%
Operating margin-343.6%
Net margin-404.8%
FCF margin—
EBITDA margin-340.0%

Returns

ROE—
ROA-286.0%
ROIC (approx.)—
Asset turnover0.71x

Leverage & solvency

Liabilities / assets924.4%
Debt / equity—
Current ratio0.07x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.36x
Accruals ratio-183.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$395,991$391,764$472,982$425,864$503,612$510,353$17,479$20,519
Cost of revenue$160,455$154,739$205,166$171,401$200,954$240,530$1,225$4,840
Gross profit$235,536$237,025$267,816$254,463$302,658$269,823$16,254$15,679
R&D expense$73,351$55,488$104,080$227,993$228,606$196,912$189,018$331,806
SG&A expense$681,559———$1.56M———
Operating income-$724,150-$1.33M-$2.27M-$1.47M-$1.86M-$1.51M-$1.01M-$1.42M
Interest expense—$3,450$5,601$5,059$2,561$4,993$7,493$7,123
Pretax income-$1.88M-$1.43M-$2.05M-$1.43M-$1.89M-$1.51M-$1.01M-$2.88M
Income tax$0$0$36,262$0$0$0-$97,279$0
Net income-$1.88M-$1.43M-$2.08M-$1.43M-$1.89M-$1.51M-$914,283-$2.88M
EBITDA-$710,812-$1.31M-$2.25M-$1.45M-$1.84M-$1.48M-$988,430-$1.40M
EPS (basic)-0.76-0.75—-0.83-1.56-1.52—-4.13
EPS (diluted)—-0.75—-0.83-1.56-1.52—-4.13
Weighted avg. shares (diluted)—1.90M—1.72M1.21M991,210—696,847
Balance sheet
Cash & equivalents$35,471$313,396$706,740$1.11M$1.55M$770,047$157,139$1.14M
Receivables$19,546$48,665$36,500$46,522$54,496$94,753$4,096—
Inventory$606,668$734,968$963,028$1.01M$1.17M$1.38M$108,705$97,890
Current assets$711,716$1.26M$1.95M$2.84M$3.24M$2.79M$955,554$1.88M
PP&E, net$75,517$87,719$101,621$116,754$117,662$138,709$113,906$131,216
Intangibles$12,822$13,958$15,094$16,231$17,367$18,504$19,641$20,778
Total assets$1.06M$1.64M$2.37M$3.30M$3.72M$3.34M$1.47M$2.44M
Current liabilities$9.59M$8.35M$7.92M$6.84M$6.91M$6.60M$5.88M$6.17M
Total liabilities$9.75M$8.54M$8.23M$7.28M$7.46M$7.14M$6.19M$6.51M
Shareholders' equity-$8.70M-$6.89M-$5.87M-$3.98M-$3.74M-$3.81M-$4.71M-$4.06M
Shares outstanding2.48M2.48M1.78M1.78M1.48M1.00M696,96920.91M
Cash flow statement
Operating cash flow-$223,881-$485,291-$306,367-$1.43M-$836,190-$752,953-$772,063-$1.40M
Capital expenditure——$1—————
Free cash flow——-$306,368—————
Investing cash flow——-$1$776-$15,000-$150,000$0$0
Financing cash flow-$54,044$91,947-$96,120$991,009$1.63M$1.52M-$208,123$341,681
Depreciation & amortization$13,338$15,038$16,271$16,268$22,184$23,952$18,447$17,978
Stock-based compensation$78,759$145,927$193,712$189,926$194,323$114,829$266,178$185,696

Free plan shows the latest 8 periods; Pro shows all 21 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.